|
Class 2 Device Recall Dade(R) Actin(R) FSL Activated PTT Reagent |
 |
Date Initiated by Firm |
March 11, 2013 |
Date Posted |
April 09, 2013 |
Recall Status1 |
Terminated 3 on December 24, 2013 |
Recall Number |
Z-1073-2013 |
Recall Event ID |
63804 |
510(K)Number |
K863594
|
Product Classification |
Test, time, partial thromboplastin - Product Code GGW
|
Product |
Dade(R) Actin(R) FSL Activated PTT Reagent.
For use in the determination of the activated partial thromboplastin time (APTT). |
Code Information |
Catalog numbers B4219-1 and B4219-2: lot numbers 547311, exp 3/22/2013; 547312, exp 3/22/2013 and 547316A, exp 4/28/2013. |
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc. 500 Gbc Dr Ms 514 PO BOX 6101 Newark DE 19702-2466
|
For Additional Information Contact |
302-631-6311
|
Manufacturer Reason for Recall |
Siemens has observed that the listed lot numbers show an increase in Heparin sensitivity over the shelf life which is demonstrated by testing with Dade(R) Citrol(R) Heparin Control, low and high.
|
FDA Determined Cause 2 |
Unknown/Undetermined by firm |
Action |
Siemens sent an "URGENT FIELD SAFETY NOTICE" dated February 2013 to all affected customers. The letter identified the product, problem, and actions to be taken by the customers. The safety notice instructed consignees to discontinue use of the affected lots and discard any remaining inventory. Contact the firm at 1-800-242-3233, option 1 for questions about this notice. |
Quantity in Commerce |
13,083 |
Distribution |
Worldwide Distribution-USA (nationwide) including the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV and Puerto Rico and the country of Canada. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = GGW and Original Applicant = AMERICAN DADE
|
|
|
|